118 related articles for article (PubMed ID: 20397919)
21. Current questions for the treatment of advanced gastric cancer.
Cervantes A; Roda D; Tarazona N; Roselló S; Pérez-Fidalgo JA
Cancer Treat Rev; 2013 Feb; 39(1):60-7. PubMed ID: 23102520
[TBL] [Abstract][Full Text] [Related]
22. What is the reference cytotoxic regimen for advanced gastric cancer: standard versus optimal therapy?
Sohal DP; Sun W
Expert Rev Anticancer Ther; 2011 Dec; 11(12):1843-50. PubMed ID: 22117152
[TBL] [Abstract][Full Text] [Related]
23. Chemotherapy with or without irinotecan in patients with advanced or recurrent gastric cancer: a meta-analysis of randomized controlled trials.
Zeng C; Zhou H; Wei Y; Wang L; Xie H; Yao W
Chin Med J (Engl); 2014; 127(5):951-6. PubMed ID: 24571893
[TBL] [Abstract][Full Text] [Related]
24. Is there a role for second-line chemotherapy in advanced gastric cancer?
Wesolowski R; Lee C; Kim R
Lancet Oncol; 2009 Sep; 10(9):903-12. PubMed ID: 19717092
[TBL] [Abstract][Full Text] [Related]
25. Second-line chemotherapy for advanced gastric cancer in Korea.
Baek SK; Kim SY; Jeong JH; Cho KS; Yoon HJ
Gastric Cancer; 2012 Oct; 15(4):345-54. PubMed ID: 22410800
[TBL] [Abstract][Full Text] [Related]
26. A review of capecitabine-based adjuvant therapy for gastric cancer in the Chinese population.
Cheng X; Lu Y
Future Oncol; 2018 Apr; 14(8):771-779. PubMed ID: 29252007
[TBL] [Abstract][Full Text] [Related]
27. Current status and future prospects of chemotherapy for metastatic gastric cancer: a review.
Ohtsu A
Gastric Cancer; 2005; 8(2):95-102. PubMed ID: 15864716
[TBL] [Abstract][Full Text] [Related]
28. Platinum-based versus non-platinum-based chemotherapy as first line treatment of inoperable, advanced gastric adenocarcinoma: a meta-analysis.
Chen WW; Wang F; Xu RH
PLoS One; 2013; 8(7):e68974. PubMed ID: 23874831
[TBL] [Abstract][Full Text] [Related]
29. [Pharmacogenomics of the first-line treatment for gastric cancer: advances in the identification of genomic biomarkers for clinical response to chemotherapy].
Castro-Rojas C; Ortiz-Lópezj R; Rojas-Martínez A
Invest Clin; 2014 Jun; 55(2):185-202. PubMed ID: 24974634
[TBL] [Abstract][Full Text] [Related]
30. [Therapeutic strategy for recurrent gastric cancer and efforts aimed at finding a cure].
Asayama M; Yamada-Murano T; Hara H; Ooki A; Yoshii T; Yamaguchi K
Gan To Kagaku Ryoho; 2013 Aug; 40(8):976-80. PubMed ID: 23986038
[TBL] [Abstract][Full Text] [Related]
31. Multidisciplinary management of gastric cancer.
Jiang Y; Ajani JA
Curr Opin Gastroenterol; 2010 Nov; 26(6):640-6. PubMed ID: 20827183
[TBL] [Abstract][Full Text] [Related]
32. A general review of the role of irinotecan (CPT11) in the treatment of gastric cancer.
Farhat FS
Med Oncol; 2007; 24(2):137-46. PubMed ID: 17848736
[TBL] [Abstract][Full Text] [Related]
33. Cutaneous metastasis resembling acute dermatitis in patient with advanced gastric cancer.
Koo DH; Chang HM; Jung JY; Song JH; Lee JL; Ryu MH; Kim TW; Yook JH; Song JS; Lee JS; Kang YK
Clin Exp Dermatol; 2007 May; 32(3):284-6. PubMed ID: 17263831
[TBL] [Abstract][Full Text] [Related]
34. Geographic differences in approach to advanced gastric cancer: Is there a standard approach?
Kim R; Tan A; Choi M; El-Rayes BF
Crit Rev Oncol Hematol; 2013 Nov; 88(2):416-26. PubMed ID: 23764501
[TBL] [Abstract][Full Text] [Related]
35. Influence of Taxanes on Treatment Sequence in Gastric Cancer.
Lorenzen S; Stahl M; Hofheinz RD; Al-Batran SE; Lordick F
Oncol Res Treat; 2020; 43(1-2):42-47. PubMed ID: 31634892
[TBL] [Abstract][Full Text] [Related]
36. Recent developments in chemotherapy of advanced gastric cancer.
Götze T; Schütte K; Röcken C; Malfertheiner P; Ebert MP
Dig Dis; 2004; 22(4):360-5. PubMed ID: 15812160
[TBL] [Abstract][Full Text] [Related]
37. Determination of prognostic factors in Japanese patients with advanced gastric cancer using the data from a randomized controlled trial, Japan clinical oncology group 9912.
Takahari D; Boku N; Mizusawa J; Takashima A; Yamada Y; Yoshino T; Yamazaki K; Koizumi W; Fukase K; Yamaguchi K; Goto M; Nishina T; Tamura T; Tsuji A; Ohtsu A
Oncologist; 2014 Apr; 19(4):358-66. PubMed ID: 24668328
[TBL] [Abstract][Full Text] [Related]
38. Metastatic gastric cancer treatment: Second line and beyond.
Ghosn M; Tabchi S; Kourie HR; Tehfe M
World J Gastroenterol; 2016 Mar; 22(11):3069-77. PubMed ID: 27003986
[TBL] [Abstract][Full Text] [Related]
39. Challenge for a better combination with basic evidence.
Yoshida K; Yamaguchi K; Osada S; Kawaguchi Y; Takahashi T; Sakashita F; Tanaka Y
Int J Clin Oncol; 2008 Jun; 13(3):212-9. PubMed ID: 18553230
[TBL] [Abstract][Full Text] [Related]
40. Management of advanced gastric cancer.
Price TJ; Shapiro JD; Segelov E; Karapetis CS; Pavlakis N; Van Cutsem E; Shah MA; Kang YK; Tebbutt NC
Expert Rev Gastroenterol Hepatol; 2012 Apr; 6(2):199-208; quiz 209. PubMed ID: 22375525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
